Bluejay Diagnostics(BJDX)
$2.16-0.14 (-5.90%)
BJDX
Bluejay Diagnostics financials statements
$2.16
At close:-0.14 (-5.90%)
Want to see BJDX full AI Analyst Report?
Bluejay Diagnostics (BJDX) Ratios
179 Followers
Bluejay Diagnostics Ratios
BJDX's free cash flow for Q3 2026 was $-2.20M. For the 2026 fiscal year, BJDX's free cash flow was decreased by $-196.82K and operating cash flow was $-2.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.88 | 6.05 | 1.82 | 7.19 | 32.43 |
| Quick Ratio | 4.88 | 6.05 | 1.82 | 7.19 | 32.43 |
| Cash Ratio | 4.61 | 5.31 | 1.25 | 6.17 | 29.89 |
| Solvency Ratio | -5.84 | -8.10 | -4.65 | -4.54 | -5.62 |
| Operating Cash Flow Ratio | -5.41 | -9.65 | -4.69 | -4.72 | -6.85 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -69.04 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 4.32M | $ 3.97M | $ 1.25M | $ 9.81M | $ 20.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.03 | 0.07 | 0.04 | 0.00 |
| Debt-to-Equity Ratio | 0.02 | 0.04 | 0.12 | 0.04 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.04 | 0.11 | 0.04 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.19 | 1.16 | 1.68 | 1.17 | 1.03 |
| Debt Service Coverage Ratio | -7958.24 | -7.15 | 0.00 | 0.00 | -8.39 |
| Interest Coverage Ratio | -8287.21 | -8.71 | 0.00 | 0.00 | -8.79 |
| Debt to Market Cap | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.08 | 22.80 | 10.30 | 15.64 | 11.69 |
| Net Debt to EBITDA | 0.76 | 0.61 | 0.20 | 1.07 | 6.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 19.64% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | -3741.48% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | -3618.46% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -3741.48% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -3733.11% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -3733.11% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -3733.11% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 106.92% |
| EBT Per EBIT | 98.50% | 107.65% | 96.53% | 99.78% | 107.99% |
| Return on Assets (ROA) | -96.20% | -115.93% | -204.45% | -68.76% | -17.74% |
| Return on Equity (ROE) | -114.61% | -134.70% | -343.85% | -80.55% | -18.30% |
| Return on Capital Employed (ROCE) | -115.88% | -122.62% | -332.93% | -78.43% | -15.85% |
| Return on Invested Capital (ROIC) | -113.98% | -120.29% | -316.28% | -77.33% | -15.85% |
| Return on Tangible Assets | -96.20% | -115.93% | -204.45% | -68.78% | -17.75% |
| Earnings Yield | -571.21% | -864.14% | -14.88% | -2.43% | -0.14% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 1.59 | 0.31 | 0.49 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -229.70 | -1159.62 | -740.87 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 229.70 | 1159.62 | 740.87 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -53.92 | -170.56 | -242.63 | -245.72 | -138.96 |
| Free Cash Flow Per Share | -55.47 | -177.25 | -263.18 | -283.78 | -139.72 |
| Dividend Paid and CapEx Coverage Ratio | -34.84 | -25.49 | -11.81 | -6.46 | -104.93 |
| Capital Expenditure Coverage Ratio | -34.84 | -25.49 | -11.81 | -6.46 | -182.35 |
| Operating Cash Flow Coverage Ratio | -50.36 | -35.18 | -23.55 | -15.72 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -31.09 | 0.00 |
| Free Cash Flow Yield | -519.40% | -909.91% | -13.48% | -2.33% | -0.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.18 | -0.12 | -6.72 | -41.20 | -690.23 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 1537.95 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.20 | 0.16 | 23.11 | 33.19 | 126.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.19 | -0.11 | -7.42 | -42.84 | -586.31 |
| Price-to-Operating Cash Flow Ratio | -0.20 | -0.11 | -8.05 | -49.47 | -589.53 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | 8.20 | -0.28 | -6.33 |
| Enterprise Value Multiple | 0.58 | 0.48 | -7.09 | -41.44 | -828.44 |
| Enterprise Value | -3.85M | -3.19M | 65.03M | 373.39M | 2.56B |
| EV to EBITDA | 0.58 | 0.48 | -7.09 | -41.44 | -828.44 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 1499.31 | 0.00 |
| EV to Free Cash Flow | 0.62 | 0.39 | -7.21 | -41.76 | -581.98 |
| EV to Operating Cash Flow | 0.64 | 0.41 | -7.82 | -48.23 | -585.17 |
| Tangible Book Value Per Share | 53.23 | 124.97 | 84.48 | 366.18 | 648.44 |
| Shareholders’ Equity Per Share | 53.23 | 124.97 | 84.48 | 366.32 | 648.58 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 7.90 | 0.00 |
| Net Income Per Share | -61.01 | -168.33 | -290.49 | -295.08 | -118.69 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.07 |
| Interest Burden | 1.00 | 1.12 | 1.00 | 1.00 | 1.08 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 16.67 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 19.13 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 1.74 | 0.00 |
| Income Quality | 0.88 | 1.01 | 0.84 | 0.83 | 1.25 |
Currency in USD

